Jorgen Petersen
Profile
Jorgen Petersen formerly worked at Genmab A, as Medical Director & Vice President and Symphogen A, as Chief Development Officer.
Mr. Petersen received his graduate degree from the University of Copenhagen.
Former positions of Jorgen Petersen
| Companies | Position | End |
|---|---|---|
| GENMAB A/S | Chief Tech/Sci/R&D Officer | - |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
Training of Jorgen Petersen
| University of Copenhagen | Graduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| GENMAB A/S | Health Technology |
| Private companies | 1 |
|---|---|
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Jorgen Petersen
